Foray Bioscience raises $3M in seed funding for predictive plant cell culture platform

In Massachusetts, Foray Bioscience, a startup sowing the seeds for plantless plant products, has raised $3 million in seed funding, led by ReGen Ventures. Additional investors include The Engine Ventures, Susquehanna Sustainable Investments, Understorey Ventures, Superorganism, and others. The seed capital follows a pre-seed round and brings the company’s total funding to $3.875 million. Foray will deploy the funds to expand its predictive plant cell culture platform, launch product development engagements with select partners, and expand its Boston-based team.

Foray’s mission is to unlock biomanufacturing for plant-based industries for the protection and restoration of natural ecosystems. The company’s novel technology uses plant cells cultivated outside of the plant to produce a variety of goods more efficiently: from molecules, to materials, and even seeds.